The Science Behind Avulux®
2016 Study: Avulux researchers tested lenses designed to block light specifically in the 480nm range, corresponding to melanopsin’s peak sensitivity. Published in the Journal of Clinical Neuroscience, the results confirmed that filtering these wavelengths had a measurable, physiological benefit for migraine sufferers.
2020 Study: Building on that success, Avulux engineered a multi-band precision filter capable of absorbing up to 97% of the most aggravating blue, amber, and red light while allowing in soothing green light. Independent, double-blind, placebo-controlled trials verified both clinical and statistical significance — solid evidence that Avulux lenses can meaningfully improve quality of life for people with migraine.
Avulux®: A New Approach to Light Sensitivity
Roughly 80% of people with migraine experience light sensitivity (photophobia). Traditional coping methods — dark rooms, heavy sunglasses, tinted coatings — offer limited help and can worsen long-term sensitivity.
Avulux solves this problem with an engineered light management system that transforms how patients interact with their environments. Each lens absorbs harmful light bands and allows beneficial wavelengths through, giving wearers that “dark room” relief without sacrificing vision or color accuracy.
Many patients describe it as “your portable dark room™” — an everyday tool that instantly eases discomfort and keeps them functioning in bright conditions.